Kamaledeen Abderahman, Young Christopher, Attia Rizwan Q
Department of Cardiothoracic Surgery, St Thomas' Hospital, London, UK.
Interact Cardiovasc Thorac Surg. 2012 Feb;14(2):205-8. doi: 10.1093/icvts/ivr012. Epub 2011 Nov 30.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: in patients with isolated right-sided infective endocarditis (RSE) is the outcome of surgical management the same as in patients with or without left-sided involvement? Altogether, 419 papers were found using the reported search, six of which represented the best evidence to answer the clinical question. Two studies point towards better outcomes with isolated RSE. In one paper, mortality was significantly lower in isolated RSE patients (P = 0.0093) for the duration of the follow-up time (median 488 patient-years). Two studies reported early mortality (<30 days) for RSE patients at 3.6 and 3.8%, respectively. Combined right- and left-sided endocarditis (RLSE) patients were found to have a poorer pre-operative clinical presentation than isolated RSE patients with a greater requirement for inotropic support (P < 0.006) and the likelihood of an emergency operation (P < 0.001). They had a poorer intra-operative course with a higher incidence of cardiac abscess formation (P < 0.001). One study suggested that there is no significant difference in in-hospital and long-term mortality between intravenous drug abuse (IVDA) patients and non-IVDA patients. Left-heart involvement in the IVDA group was 61.5%. This was in-line with the published literature, demonstrating a rise in RLSE in IVDA compared with non-IVDA patients. Three articles looking at isolated left-sided endocarditis (LSE) gave mortality rates in the surgical group to be 27.1, 27.8 and 38%, respectively. In one study, the LSE mortality was not different for native vs. prosthetic valve infection (OR 0.65, 95% CI 0.23-1.87). After propensity matching and adjusting for hazards, the complication rate in the LSE group was higher and this translated to a higher mortality rate. We conclude from the literature that outcomes are more favourable with lower early and late mortality for isolated RSE patients over pure LSE or combined RLSE.
根据结构化方案撰写了一篇心脏外科的最佳证据主题。所探讨的问题是:在单纯右侧感染性心内膜炎(RSE)患者中,手术治疗的结果与有或无左侧受累的患者是否相同?通过报告的检索共找到419篇论文,其中6篇代表了回答该临床问题的最佳证据。两项研究表明单纯RSE患者的预后更好。在一篇论文中,单纯RSE患者在随访期间(中位488患者年)的死亡率显著更低(P = 0.0093)。两项研究报告RSE患者的早期死亡率(<30天)分别为3.6%和3.8%。发现右侧和左侧联合心内膜炎(RLSE)患者术前临床表现比单纯RSE患者差,对血管活性药物支持的需求更大(P < 0.006),且急诊手术的可能性更高(P < 0.001)。他们术中过程较差,心脏脓肿形成的发生率更高(P < 0.001)。一项研究表明,静脉药物滥用(IVDA)患者与非IVDA患者在住院和长期死亡率方面无显著差异。IVDA组左心受累率为61.5%。这与已发表的文献一致,表明与非IVDA患者相比,IVDA患者中RLSE有所增加。三篇关于单纯左侧感染性心内膜炎(LSE)的文章给出手术组的死亡率分别为27.1%、27.8%和38%。在一项研究中,天然瓣膜感染与人工瓣膜感染的LSE死亡率无差异(OR 0.65,95% CI 0.23 - 1.87)。在进行倾向匹配和风险调整后,LSE组的并发症发生率更高,这导致死亡率更高。我们从文献中得出结论,与单纯LSE或联合RLSE相比,单纯RSE患者的早期和晚期死亡率更低,预后更有利。